Chantix litigation against Pfizer, the manufacturer of the smoking cessation drug, continues to mount. The lawsuits against Pfizer focus on the drug’s link to suicide and depression. According to the Journal of the American Medical Association (JAMA), as of July 2009, the FDA received 90 reports of suicide and 188 reports of suicide attempts. In response to the apparent dangers of Chantix, the FDA required Pfizer to place a black box warning label on Chantix. As Chantix litigation increases, sales of the drug continue to drop. In fact, Chantix sales decreased 15% in the third quarter of 2009. The Chantix litigation alleges that Pfizer, in distributing Chantix, did not fully disclose its risks, including depression and suicidal ideations.

Chantix Litigation in Federal Court

In 2009, there were 37 Chantix lawsuits filed in federal court. In response to the growing Chantix litigation, these lawsuits were consolidated through a Multi-District Litigation (MDL). In October 2009, the Judicial Panel on Multidistrict Litigation ordered all Chantix litigation filed in federal court to be consolidated to the Northern District of Alabama in front of Judge I. Johnson for pre-trial procedures. This process will make Chantix litigation more efficient for all parties, cutting down on duplicative discovery and assuring uniform rulings. 

Chantix Litigation in New York State Court

In January 2010, three lawsuits were filed in New York State Supreme Court. Of the three Chantix lawsuits filed in NY, two Chantix complaints were brought by plaintiffs who claim that after taking Chantix, they attempted suicide. The third Chantix complaint was filed on behalf of a woman who committed suicide. All of the Chantix litigation alleges that Pfizer intentionally, recklessly, and/or negligently concealed, suppressed, omitted, and/or misrepresented the risks, dangers, defects and disadvantages of Chantix.

Chantix Litigation Claims

The lawsuits surrounding Chantix allege that Pfizer, during clinical trials, did not include individuals with psychiatric history or current psychiatric symptoms. Because Chantix was not tested among people with common psychiatric conditions like depression, bipolar disorder and schizophrenia, the complaints allege that the drug was not properly vetted before being released. The Chantix litigation also concerns allegations that Pfizer did not adequately notify doctors nor warn patients about Chantix’s potential harmful effects.

Chantix Litigation: Filing a Complaint

If you or a loved one have been injured by Chantix, you may be able to file a lawsuit seeking compensation for:

  • Medical Expenses
  • Loss of Income
  • Partial or Permanent Disability
  • Psychological Suffering

Information on Chantix Litigation

If you have any questions or need additional information on Chantix, the Chantix litigation team at our firm is available to help. Please contact us today to assess your potential claim.

Published November 17, 2011 by